Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flomentum Health is a consumer health and nutraceutical company focused on prostate and urinary health products for men. Its flagship commercial product, Flomentum, is a saw palmetto oil extract supplement positioned as a clinically backed, USP-verified prostate health supplement that supports urinary flow and reduces urinary frequency. The company markets Flomentum as being supported by decades of research and more than 50 clinical studies on standardized saw palmetto extract, and manufactured in an FDA-registered facility. Flomentum Health appears to operate primarily as a single-product branded supplement business rather than a traditional drug-development biotech. The brand has been acquired by Basic Brands and is currently sold through the Flomentum website and retail channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flomentum Health.